Opko Health shares climb after FDA approves hormone treatment
June 21, 2016 at 12:47 PM EDT
Opko Health rose more than 5 percent after the U.S. Food and Drug Administration approved the drug Rayaldee.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|